Gammelmark Anders, Lundbye-Christensen Søren, Tjønneland Anne, Schmidt Erik B, Overvad Kim, Nielsen Michael S
Department of Cardiology,
Department of Clinical Medicine, and.
J Nutr. 2017 Jul;147(7):1340-1347. doi: 10.3945/jn.117.247569. Epub 2017 May 31.
The 5-lipoxygenase pathway has been linked to atherothrombotic disease, and a functional tandem repeat polymorphism in the arachidonate lipoxygenase-5 () gene has been associated with the risk of myocardial infarction (MI). Interestingly, 2 studies have reported an interaction between dietary intakes of the ALOX-5 substrates, arachidonic acid (AA) and eicosapentaenoic acid (EPA), and genotype. We investigated whether the interactions between the tandem repeat polymorphism (rs59439148) and adipose tissue AA and EPA were associated with incident MI. In the Danish Diet, Cancer and Health study, we conducted a case-cohort study including 3089 participants with incident MI identified from national registries and a randomly selected subcohort of 3000 participants. Participants were men and women with a median age of 56 y at baseline and no previous history of cancer. Adipose tissue and blood samples were collected at baseline along with comprehensive questionnaires on lifestyle and demographic data. The tandem repeat polymorphism was genotyped by multititer plate sequencing. Associations were analyzed by using Cox proportional hazards models. We observed a higher risk of MI for homozygous carriers of the variant alleles in the fifth quintile of AA content than for the reference group with the lowest quintile of AA and carrying the wild-type allele (HR: 3.02; 95% CI: 1.41, 6.44). In contrast, homozygotes for the variant alleles tended to have a higher risk of MI when comparing the lowest quintile of EPA content with the reference group with the highest quintile of EPA and carrying the wild-type allele (HR: 2.15; 95% CI: 0.91, 5.09; = 0.08). Although our results suggested interactions between the polymorphism and adipose tissue AA and EPA, a quantitative evaluation of interaction by calculating the relative excess risk due to interactions was not significant. Adipose tissue EPA and AA and the tandem repeat polymorphism did not significantly interact to affect the risk of MI. However, the results should be replicated in larger, heterogeneous populations.
5-脂氧合酶途径与动脉粥样硬化血栓形成疾病有关,花生四烯酸脂氧合酶-5(ALOX-5)基因中的一种功能性串联重复多态性与心肌梗死(MI)风险相关。有趣的是,有两项研究报告了ALOX-5底物花生四烯酸(AA)和二十碳五烯酸(EPA)的饮食摄入量与基因型之间的相互作用。我们调查了串联重复多态性(rs59439148)与脂肪组织中AA和EPA之间的相互作用是否与新发MI有关。在丹麦饮食、癌症与健康研究中,我们进行了一项病例队列研究,包括从国家登记处确定的3089例新发MI参与者以及随机选取的3000名参与者的亚队列。参与者为男性和女性,基线时中位年龄为56岁,且无癌症病史。在基线时采集脂肪组织和血液样本,同时收集关于生活方式和人口统计学数据的综合问卷。通过多滴定板测序对串联重复多态性进行基因分型。使用Cox比例风险模型分析关联。我们观察到,与AA含量最低五分位数且携带野生型等位基因的参考组相比,AA含量第五五分位数中变异等位基因纯合携带者发生MI的风险更高(风险比:3.02;95%置信区间:1.41,6.44)。相比之下,当将EPA含量最低五分位数与EPA含量最高五分位数且携带野生型等位基因的参考组进行比较时,变异等位基因纯合子发生MI的风险往往更高(风险比:2.15;95%置信区间:0.91,5.09;P = 0.08)。尽管我们的结果表明该多态性与脂肪组织中AA和EPA之间存在相互作用,但通过计算因相互作用导致的相对超额风险对相互作用进行的定量评估并不显著。脂肪组织中EPA和AA以及串联重复多态性并未显著相互作用以影响MI风险。然而,这些结果应在更大的异质性人群中进行重复验证。